Search
for

    Sort by

    Research 151–180 of 1000+

    1. Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment Journal of Infection · 2022 · 3 citations
    2. Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2 Frontiers in Immunology · 2023 · 3 citations
    3. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism Viruses · 2021 · 50 citations
    4. SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation Life · 2023 · 2 citations
    5. Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development Frontiers in Pharmacology · 2022 · 17 citations
    6. Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia Medical Gas Research · 2023 · 13 citations
    7. Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury Scientific Reports · 2021 · 5 citations
    8. Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation The Egyptian Journal of Internal Medicine · 2022 · 12 citations
    9. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia International Journal of Infectious Diseases · 2021 · 38 citations
    10. Sex hormones in SARS-CoV-2 susceptibility: key players or confounders? Nature Reviews Endocrinology · 2022 · 8 citations
    11. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system 2021 · 6 citations
    12. From bedside to bench: regulation of host factors in SARS-CoV-2 infection Experimental and Molecular Medicine · 2021 · 4 citations
    13. Genetic and hormonal influence on SARS-CoV-2-infection susceptibility Annals of Oncology · 2020 · 2 citations
    14. Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 <i>in vitro</i> infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 13 citations
    15. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action Heliyon · 2024 · 2 citations
    16. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients Briefings in Bioinformatics · 2020 · 82 citations
    17. Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis Healthcare · 2022 · 10 citations
    18. Genetic Variants and Protective Immunity against SARS-CoV-2 Genes · 2022 · 5 citations
    19. Research progress of post-acute sequelae after SARS-CoV-2 infection Cell death and disease · 2024
    20. Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship BioMed · 2023 · 15 citations
    21. Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland Journal of Clinical Medicine · 2021 · 12 citations
    22. The role of medicinal plants in the treatment of Coronavirus infections Annals of Institute of Biology University of Sarajevo · 2022
    23. Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2 Clinical Therapeutics · 2021 · 22 citations
    24. Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight Biomolecules · 2022 · 21 citations
    25. Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review Biomedicine & Pharmacotherapy · 2022 · 202 citations
    26. Comprehensive Review of Perilla frutescens: Chemical Composition, Pharmacological Mechanisms, and Industrial Applications in Food and Health Products Foods · 2025 · 16 citations
    27. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review Prostate Cancer and Prostatic Diseases · 2021 · 21 citations
    28. Covid-19 in Lupus Nephritis Bioscientia Medicina Journal of Biomedicine and Translational Research · 2021
    29. Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19 Journal of the European Academy of Dermatology and Venereology · 2020 · 29 citations
    30. Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes Dermatology Practical & Conceptual · 2024